Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia

Respir Res. 2024 Jan 18;25(1):35. doi: 10.1186/s12931-024-02687-4.

Abstract

Background: This study aimed to investigate the interactions among three core elements of respiratory infection-pathogen, lung microbiome, and host response-and their avocation with the severity and outcomes of Mycoplasma pneumoniae pneumonia (MPP) in children.

Methods: We prospectively collected bronchoalveolar lavage fluid from a cohort of 41 children with MPP, including general MPP (GMPP) and complicated MPP (CMPP), followed by microbiome and transcriptomic analyses to characterize the association among pathogen, lung microbiome, and host response and correlate it with the clinical features and outcomes.

Results: The lung microbiome of patients with CMPP had an increased relative abundance of Mycoplasma pneumoniae (MP) and reduced alpha diversity, with 76 differentially expressed species. Host gene analysis revealed a key module associated with neutrophil function and several inflammatory response pathways. Patients with a high relative abundance of MP, manifested by a specific lung microbiome and host response type, were more prone to CMPP and had a long imaging recovery time.

Conclusion: Patients with CMPP have a more disrupted lung microbiome than those with GMPP. MP, lung microbiome, and host response interacts with each other and are closely related to disease severity and outcomes in children with MPP.

Keywords: Host response; Microbiome; Mycoplasma pneumoniae; Neutrophils; Outcomes.

MeSH terms

  • Child
  • Humans
  • Lung
  • Mycoplasma pneumoniae* / genetics
  • Nitrobenzenes*
  • Organophosphorus Compounds*
  • Pneumonia, Mycoplasma* / diagnosis
  • Pneumonia, Mycoplasma* / genetics
  • Transcriptome

Substances

  • 4-nitrophenyl chloromethyl(phenyl)phosphinate
  • Nitrobenzenes
  • Organophosphorus Compounds